Chapter
Biotech Investment Rush in Pursuit of Youth
1:01:48 - 1:09:39 (07:51)
Biotech investments will lead to discoveries about Yamanaka factor-based cell reprogramming, triggering partial cell reprogramming and causing cells to act youthful, resulting in magazine covers and 60 Minutes articles in 2022. Capital formation globally will be empowered by combining regulations, using syndicates, dows, and tokens in the investment process.
Clips
The speaker believes that early stage startups will be the best performing asset in 2022 due to spacking, direct listings, and raising money, among others.
1:01:48 - 1:04:33 (02:45)
Summary
The speaker believes that early stage startups will be the best performing asset in 2022 due to spacking, direct listings, and raising money, among others. Additionally, he/she highlighted a contrarian bet on increased global conflict caused by incumbents' efforts to hold on to political power and fuel economic growth, which further supports the potential for early stage startups to outperform other assets.
ChapterBiotech Investment Rush in Pursuit of Youth
EpisodeE61: 2022 Predictions! Business, politics, science, tech, crypto, & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
Yamanaka factor-based cell reprogramming methods have been identified as a means to trigger partial cell reprogramming, which enables cells in the body to behave young again.
1:04:33 - 1:09:39 (05:05)
Summary
Yamanaka factor-based cell reprogramming methods have been identified as a means to trigger partial cell reprogramming, which enables cells in the body to behave young again. This innovation will lead biotech investments that will uncover the fountain of youth, causing a trend in magazine covers, articles, and breakthrough discoveries in 2022.